Dapeng Li
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
TP53 Mutation and Tumor-Infiltrating Lymphocytes as Predictors of PD-1/PD-L1 Inhibitor Efficacy in PD-L1-High Advanced NSCLC.
Journal: Cancer reports (Hoboken, N.J.)
Published: April 16, 2026
Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy.
Journal: Cell host & microbe
Published: September 30, 2025
CCNY-mediated phosphorylation and TET2-BACH1-driven DNA demethylation activate PRC1 to augment NSCLC progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 21, 2025
The TEAD4-DYNLL1 axis accelerates cell cycle progression and augments malignant properties of lung adenocarcinoma cells.
Journal: European journal of medical research
Published: January 23, 2025
Peripheral Blood Markers Predictive of Progression-Free Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Treated With PD-1 Inhibitors Plus Chemotherapy as First-Line Therapy.
Journal: Nutrition and cancer
Published: October 03, 2022
Peripheral absolute eosinophil count identifies the risk of serious immune-related adverse events in non-small cell lung cancer.
Journal: Frontiers in oncology
Published: July 27, 2022
Falnidamol and cisplatin combinational treatment inhibits non-small cell lung cancer (NSCLC) by targeting DUSP26-mediated signal pathways.
Journal: Free radical biology & medicine
Published: December 11, 2021
Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression.
Journal: Annals of translational medicine
Published: November 19, 2020
TPD52L1-ROS1 Rearrangement as a New Acquired Resistance Mechanism to Osimertinib That Responds to Crizotinib in Combination With Osimertinib in Lung Adenocarcinoma.
Journal: JTO clinical and research reports
Published: March 08, 2020
Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels.
Journal: BMC cancer
Published: January 10, 2020
ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Journal: International journal of biological sciences
Published: July 10, 2018
Last Updated: 09/26/2026